Showing 2721-2730 of 3872 results for "".
- Radiofrequency Microneedling: Optimize Your Resultshttps://modernaesthetics.com/news/radiofrequency-microneedling-optimize-your-results/2473417/For optimal results when treating patients with radiofrequency (RF) microneedling, anecdotal and personal experience guide Elizabeth L. Tanzi, MD, as there are “No significant comparison studies to date” on the
- Reveal Lasers Launches Eternahttps://modernaesthetics.com/news/reveal-lasers-launches-eterna-topic/2473419/Reveal Lasers LLC is launching Eterna, a radiofrequency device that reduces fine lines and wrinkles, tightens skin through soft tissue coagulation and does not require consumables. "We are thrilled to introduce Eterna to the market," says Bob Daley, CEO of Reveal Lasers, in a
- Cartessa Aesthetics Introduces Helix by DEKAhttps://modernaesthetics.com/news/cartessa-aesthetics-introduces-helix-by-deka/2473418/Cartessa Aesthetics is rolling out Helix by DEKA, a fractional ablative CO2 and non-ablative technologies in one device. The US is the first market to make HELIX commercially available. HELIX features pulse shape control for CoolPeel treatment and adds a 1570nm fiber lase
- Evolus Acquires Exclusive US Distribution Rights to Evolysse Line of Dermal Fillershttps://modernaesthetics.com/news/evolus-acquires-exclusive-us-distribution-rights-to-evolysse-line-of-dermal-fillers/2473412/Evolus has entered into a definitive agreement to be the exclusive US distributor of a line of five dermal fillers currently in late-stage development. Evolus is partnering with Symatese, a privately held French company, to introduce the Evolysse line to its US customers beginning
- TAKE 5 WITH PETER KANG, CEO, COOLHEALTHhttps://modernaesthetics.com/news/take-5-with-peter-kang-ceo-coolhealth/2473406/Peter Kang, CEO of CoolHealth, chatted with Modern Aesthetics® magazine about the company and their first launch. TargetCool, a cooling device that takes cooling to the next level, provides temporary analgesia to the skin before aesthetic injections including fillers, neuromodulators, and pla
- Aquavit Files Investigational New Drug Application for Intradermal Dermatoxhttps://modernaesthetics.com/news/aquavit-files-investigational-new-drug-application-for-intradermal-dermatox/2473405/Aquavit has filed an Investigational New Drug Application with the U.S Food and Drug Administration (FDA) for Dermatox (aqubotulinumtoxinA), their intradermal injection of botulinum toxin. AqubotulinumtoxinA has already received regulatory approvals in Asia, Sou
- Meet ASERF's New President: Dr. Caroline Glicksmanhttps://modernaesthetics.com/news/meet-aserfs-new-president-dr-caroline-glicksman/2473397/Sea Girt, NJ-based plastic surgeon Caroline Glicksman, MD, MSJ, is the new President of
- New from BTL: Meet EXIONhttps://modernaesthetics.com/news/new-from-btl-meet-exion/2473392/Just in time for their 30th anniversary, BTL is launching EXION, a multiplatform device featuring micro-needling RF, a non-invasive face and body applicator for skin laxity, and the EMFEMME 360 applicator for intimate health. EXION can also be combined with EMFACE to treat bot
- Dermalogica Offers Digital Accreditation Badge for Beauty Proshttps://modernaesthetics.com/news/dermalogica-offers-digital-accreditation-badge-for-beauty-profs/2473391/Dermalogica is launching a new medispa accreditation for professional skin therapists. Launching April 17, 2023, the program aims to raise industry standards and provide more transparency to consumers. Unlike state board requirements that lead to esthetics licensing, the
- Updated: Cutera CEO, Executive Chairman Axedhttps://modernaesthetics.com/news/cutera-ceo-top-investor-call-for-removal-of-board-members/2473390/Cutera Inc has fired CEO David Mowry and Executive Chairman Daniel Plants for alleged violations of their employment contracts. Sheila Hopkins has been appointed as interim CEO and the search for a permanent replacement is underway. Plants and Mowry called for a Spec